AAMDSIF advocates for and invests in collaborative research to accelerate the discovery of better treatments and cures for bone marrow failure disorders.
AAMDSIF Research Grants
The Aplastic Anemia and MDS International Foundation, Inc. (AAMDSIF) is pleased to offer research grants to investigators dedicated to studying bone marrow failure and advancing the understanding, prevention and treatment of bone marrow disorders in both pediatric and adult populations. Since 1989, AAMDSIF has provided financial support for research that leads to new insights into the causes of bone marrow failure diseases and to the development of new therapeutic approaches. The 2025 program will accept applications in the following types of research:
• Basic research
• Translational research
• Pre-clinical research (e.g. drug development)
• Early-stage clinical research
• Health services research/epidemiology
Deadlines:
Required Letters of Intent Submission Deadline: June 30, 2025
Applications Due: October 31, 2025
In 2025, AAMDSIF will accept proposals addressing these bone marrow failure disorders:
A) Aplastic Anemia Funding is available to support one project at $60,000 over two years ($30,000 per year) judged to have the highest scientific merit by the AAMDSIF Medical Advisory Board reviewers.
B) Myelodysplastic Syndromes/Neoplasms (MDS), including MDS transition to Acute Myeloid Leukemia (AML) Funding is available to support one project at $60,000 over two years ($30,000 per year) judged to have the highest scientific merit by the AAMDSIF Medical Advisory Board reviewers.
There are no nationality restrictions. Research may be conducted in the United States or abroad but not at a for-profit laboratory in the private sector. The project must represent independent research conducted by the applicant. Members of the AAMDSIF Medical Advisory Board are not eligible to apply for a grant and may sponsor no more than one applicant during any given round. Preference will be given to New Investigators who propose a project that will contribute toward their professional development in bone marrow failure disease research. New Investigators are post-doctoral fellows, instructors, and those who have been assistant professors for fewer than five (5) years.